Association between Glucagon-Like Peptide-1 Receptor Agonists Use and Change in Alcohol Consumption: A Systematic Review. eClinicalMedicine , vol
Other side effects Retatrutide trials have also reported the following side effects, though theyre less common: 1,2,3 Injection site reactions
The article advises against abrupt stopping and describes a gradual reduction over two to four weeks under provider supervision, arguing it eases the transition and creates time to reinforce diet and exercise habits
Jung J, Ku M, Jeong S, Yoon N, Park JH, Youn HS, Yang J, Seo S
DSIP is used for studying neuroendocrine mechanisms and has no approved therapeutic dose
Synergistic Peptides + Use: Ipamorelin (synergistic GH release) BPC-157 (recovery)